Reuters logo
4 months ago
BRIEF-Synergy Pharmaceuticals announces issuance of three new patents expected to extend Trulance patent protection until 2032
April 12, 2017 / 12:15 PM / 4 months ago

BRIEF-Synergy Pharmaceuticals announces issuance of three new patents expected to extend Trulance patent protection until 2032

April 12 (Reuters) - Synergy Pharmaceuticals Inc

* Announces issuance of three new patents expected to extend Trulance (Plecanatide) patent protection until 2032

* United States Patent and Trademark Office (USPTO) has issued three new patents covering Trulance (Plecanatide) Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below